Their stock opened with $15.00 in its Oct 9, 2019 IPO. Related Quotes. Denver, CO 80237-2733 Corporate Stock Transfer BioNTech Investor Relations Sylke Maas, Ph.D. VP Investor Relations & Business Strategy Tel: +49 (0)6131 9084 1074 E-mail: Investors@biontech.de. Investor Relations Sylke Maas, Ph.D. +49 (0)6131 9084 1074 Investors@biontech.de Bion’s proven solution, coupled with an experienced and dedicated management team that has a deep understanding of the issues, positions the company to succeed as this opportunity continues to unfold. BioNTech: Media Relations Jasmina Alatovic +49 (0)6131 9084 1513 Media@biontech.de. An increasing circle of stakeholders understand this need, as well: federal and state policies are evolving to encourage and support/ fund livestock waste cleanup. The announcement stated, “EPA efforts seek to modernize the agency’s water quality trading policies to leverage emerging technologies and facilitate broader adoption of market-based programs.”. In a recent Letter of Expectation (click for highlighted version), US EPA made it clear to Pennsylvania that the agency supports and encourages the use of credit trading, competitive procurement and other market-driven strategies to comply with the Commonwealth’s Bay mandates. Investor Relations Chuck Triano +1 (212) 733-3901 Charles.E.Triano@Pfizer.com. Our broad portfolio of oncology product candidates includes individualized and off-the-shelf mRNA-based therapies, innovative chimeric antigen receptor T cells, bi-specific checkpoint immuno-modulators, targeted cancer antibodies and small molecules. Sylke Maas-- Vice President, Investor Relations, and business Strategy Thank you for joining us today for BioNTech's fourth quarter and full-year 2019 update call. use our contact form atconnect.biontech.de, We aspire to utilize the full potential of the immune system to fight cancer and infectious diseases, Our vision: individualize cancer medicine, How we approach individualized cancer medicine, Why mRNA represents a disruptive new drug class, Beyond mRNA: Expanding therapeutics with our antibody discovery engines, Explore our individualized immunotherapy pipeline, Tour our platforms that produce individually-tailored therapeutics, Our Mission: broaden the therapeutic universe to benefit patients. A Focus on Market-Driven Strategies Could Provide Much-Needed Change, It is anticipated that an Administration focused on reducing the scale and cost of government will embrace market-driven solutions, such as Bion provides, that can deliver much lower-cost results to the taxpayer, while providing substantially greater certainty and less risk. The U.S. livestock industry must reduce its footprint and simultaneously improve its efficiencies if it is to remain environmentally and economically sustainable in the modern world. BioNTech’s Media Relations Jasmina Alatovic Senior Manager Global External Communications Tel: +49 (0)6131 9084 1513 or +49 (0)151 1978 1385 E-mail: Media@biontech.de. Pfizer-BioNTech vaccine can produce antibodies, immune cells 12 days after first dose: S'pore study Nation 22h ago Khairy: 585 vials of Pfizer's Covid-19 … And Bion’s expertise, coupled with its technology solutions that have been proven over many years, place it far ahead of future competitors in this evolving space. Germany, For questions on logistics, National livestock interests, including National Milk Producers Federation, Land O’Lakes, Dairy Farmers of America, JBS (the largest beef/pork producer in the world), Pennsylvania Farm Bureau, and others have recently joined Bion in support of such a strategy. Investor Relations Sylke Maas, Ph.D. +49 (0)6131 9084 1074 Bion Environmental Technologies, Inc., is publicly-traded on the OTC Markets QB: BNET. Companies on the cutting edge of these efforts, like Bion, can change the entire way that farming and natural resource management have been done throughout our history. Large-scale livestock production facilities – CAFOs (Concentrated Animal Feeding Operations) – deal with their waste today much as farmers did 150 years ago. Production agriculture, environmental necessities and raw economics are coming together like never before. Media Relations Andrew Widger +44797 0149098 andrew.widger@pfizer.com. Legislation to establish a competitively-bid procurement program in Pennsylvania, which will allow Bion and other private-sector providers to sell low-cost nutrient credits to the state, was introduced in the PA Senate in June 2017; in February 2018, the bill passed in the Senate 47-2, but was not considered in the House. BioNTech SE An der Goldgrube 12 55131 Mainz Germany. Companies on the cutting edge of these efforts, like Bion, can change the entire way that farming and natural resource management have been done throughout our history. Media Relations Amy Rose +1 (212) 733-1226 PfizerMediaRelations@pfizer.com Investor Relations Chuck Triano +1 (212) 733-3901 Charles.E.Triano@Pfizer.com BioNTech: Media Relations Jasmina Alatovic +49 89 62 81 75 46 Media@biontech.de Investor Relations Sylke Maas, Ph.D. +49 (0)6131 9084 1074 Investors@biontech.de. Food safety, corporate social responsibility and improved sustainability in production are increasingly demanded by the consumer. BioNTech’s Investor Relations Sylke Maas, Ph.D. VP Investor Relations & Business Strategy Tel: +49 (0)6131 9084 1074 E-mail: Investors@biontech.de. While the policy changes we support are still a major focus of our business, we are no longer entirely dependent on them. BioNTech: Media Relations Jasmina Alatovic +49 89 62 81 75 46 Media@biontech.de. Investor Relations Chuck Triano +1 (212) 733-3901 Charles.E.Triano@Pfizer.com. Pfizer Investor Relations Chuck Triano +1 (212) 733-3901 Charles.E.Triano@Pfizer.com. Investors in BioNTech SE (Symbol: BNTX) saw new options become available today, for the April 30th expiration. The bill was approved in the Senate in a bipartisan vote and is now in the House State Government Committee. The bottom line is that Bion can provide verified nitrogen reductions at $10 to $12 per pound per year, at scale, where the state is facing costs starting at $30 per pound and climbing into the hundreds. © 2018 Bion Environmental Technologies. Investor Relations Sylke Maas, Ph.D. +49 (0)6131 9084 1074 Investors@biontech.de. At Stock Options Channel, our YieldBoost … The Investor Relations website contains information about BioNTech's business for stockholders, potential investors, and financial analysts. Investor Relations Sylke Maas, Ph.D.VP Investor Relations & Business StrategyTel: +49 (0)6131 9084 1074E-mail: Investors@biontech.de. Bion Announces Core Optimization Trials Complete, Shareholder Alert – Bion Enters USEPA-USDA Next Gen Fertilizer Challenge, Bion Announces New U.S. Patent Provides Stronger Coverage of Third-Gen Technology. Environmentally Sustainable Livestock Production. Verifying the removal of these coproducts (formerly pollutants) from the waste stream produces additional revenues from the sale of renewable energy and carbon credits, as well as nutrient credits described below. Bion’s business model, coupled with the policy change it supports, provides the industry a pathway to sustainability, without bankrupting it. Based on our deep expertise in mRNA vaccine development and in-house manufacturing capabilities, we and our collaborators are developing multiple mRNA vaccine candidates for a range of infectious diseases alongside a diverse oncology pipeline. Investors in BioNTech SE (Symbol: BNTX) saw new options begin trading today, for the April 9th expiration. T: +49 6131 9084-0 For questions on logistics, handling or other issues: service@biontech.de For any other questions, please use our contact form at connect.biontech.de. Bion’s technology platform provides low-cost high-impact solutions to the industry’s environmental and public health issues AND delivers substantially better efficiencies and economics simultaneously. The opportunity is to clean up livestock production, the ‘dirtiest’ part of the food supply chain…and the largest unregulated source of pollution in the U.S. Bion’s technology provides a ‘cleantech makeover’ for large-scale livestock production, with dramatic reductions in environmental impacts and significant improvements to resource and operational efficiencies. This is a true game-changer for Bion. BioNTech Investor Relations Sylke Maas, Ph.D. VP Investor Relations & Business Strategy Tel: +49 (0)6131 9084 1074 E-mail: Investors@biontech.de. The Director/Senior Director, Capital Markets & Investor Relations will be responsible for ensuring BioNTech is strategically positioned with external stakeholders in the US. Michelle Vigil, public relations manager, told CNN on Tuesday that San Antonio is "currently operating at a 25% occupancy and will require masks for … The industry is under attack for these impacts from a wide range of detractors and competitors and they are losing customers at an alarming rate. Documents on this website contain forward-looking statements based on management’s current reasonable business expectations. Bion’s technology platform can provide measurable and verifiable sustainability metrics – carbon and nutrient footprint; impacts to water, soil and air; pathogen destruction –  that are unmatched in the industry today. Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evalu.. March 15, 2021 from 5:00 PM to 6:00 PM EDT. Biopharmaceutical New Technologies is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. These credits, coupled with the pipeline-quality natural gas, high-value fertilizer, and feed products, represent the recurring revenues needed to offset technology adoption costs. Margins across the supply chain have suffered. Assets that have traditionally been wasted or underutilized – renewable energy and nutrients – are recovered and converted into high-value coproducts. Denver, CO 80209 Production agriculture, environmental necessities and raw economics are coming together like never before. Bion Environmental Technologies’ (OTC QB: BNET) patented and proven technology provides advanced waste treatment and resource recovery for large-scale livestock production facilities – dairy, meat and egg producers. Policies are now changing to support market-based strategies that engage the private sector to provide lower cost solutions. BioNTech has established a broad set of relationships with multiple global pharmaceutical collaborators, including Genmab, Sanofi, Bayer Animal Health, Genentech, a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. BioNTech SE. handling or other issues:service@biontech.de, For any other questions, please Whole Foods, Walmart, Costco, McDonalds, and most other large meat and dairy product retailers have recently announced sustainability initiatives. Many of us here in Pennsylvania have taken our role as protectors of our land, our environment and the Chesapeake Bay very seriously and that’s why our partnership with Bion made sense from day one. One of Germany’s wealthiest software tycoons is the biggest shareholder in CureVac, a company racing to develop a coronavirus vaccine. E-mail: Media@biontech.de. Investor Relations Chuck Triano +1 (212) 733-3901 Charles.E.Triano@Pfizer.com. Investor Relations Chuck Triano +1 (212) 733-3901 Charles.E.Triano@Pfizer.com. Investor Relations Chuck Triano +1 (212) 733-3901 Charles.E.Triano@Pfizer.com. Source: Pfizer Inc. While policy change is taking place, recent improvements to Bion’s technology platform – our recently patented Third Generation (3G) technology platform – will enable the recovery of much higher-value coproducts and renewable energy than previous generations. Eide Bailly, LLP Expansion without corresponding environmental impact is the kind of agricultural growth needed to provide jobs and opportunities in rural America. For the most part, the industry has been unable to relocate or consolidate to mitigate these effects because of the environmental impacts of production. Since late in 2018, the US EPA and USDA have signaled several times that they support market-driven strategies, such as ‘reverse auctions’ (competitive procurement) and trading. Pfizer Media Relations To learn more about this evolving opportunity, which is poised to receive billions in federal, state, local and private funding, please visit Excess Nutrients – the Challenge, Bion’s Technology, Benefits, and Policy Change. BioNTech Media Relations Jasmina Alatovic Senior Manager Global External Communications Tel: +49 (0)6131 9084 7640 or +49 (0)151 1978 1385 E-mail: Media@biontech.de. 3200 Cherry Creek Dr. South, Ste 430 303.282.4800. Ceres and other large activist institutional investors have already expressed concerns about carbon footprint, water quality, antibiotic usage and animal welfare to many in the food production industry. cleaner water…cleaner air…better economics. 303.770.5700, Transfer Agent The re-allocation of significantly more funding to non-point source pollution sources, particularly agriculture, is inevitable if we are to maintain the integrity of the environment and our water resources. Bion expects it to be adopted and signed by the Governor in 2020. BioNTech Media Relations Jasmina Alatovic Senior Manager Global External Communications Tel: +49 (0)6131 9084 7640 or +49 (0)151 1978 1385 E-mail: media@biontech.de. Global Media Relations Contact Sharon Castillo +1 202.624.6769 Sharon.Castillo@Pfizer.com. Bion’s technology produces a number of additional benefits, at no additional cost. In February 2019, EPA issued a memorandum updating its water quality trading policy to support market-based approaches to reduce nutrient pollution in the nation’s waterways. An unintended consequence of siting large-scale facilities in out-of-the-way locations has been a significant increase in transportation costs and impacts. Symbol Some of the largest national producers in the livestock industry are at the table with Bion, ready and willing to be engaged. Media Relations Amy Rose +1 (212) 733-7410 Amy.Rose@pfizer.com Investor Relations Chuck Triano +1 (212) 733-3901 Charles.E.Triano@Pfizer.com BioNTech: Media Relations Jasmina Alatovic +49 (0)6131 9084 1513 or +49 (0)151 1978 1385 Media@biontech.de Investor Relations Sylke Maas, Ph.D. +49 (0)6131 9084 1074 Investors@biontech.de. Investor Relations Sylke Maas, Ph.D. +49 (0)6131 9084 1074 Investors@biontech.de. Livestock production is recognized as one of the largest sources of excess nutrients in most major watersheds. We aspire to utilize the full potential of the immune system to fight cancer and infectious diseases We believe that as these initiatives move forward, ‘sustainability’ on the production side will look a lot like what Bion can provide today. Bion’s verified results will back both a USDA-certified sustainable brand that will regain and hold the confidence and trust of its consumers, as well as water quality improvements that will save taxpayers billions of dollars. BioNTech Contacts: Media Relations Jasmina Alatovic +49 6131 9084-0 Media@biontech.de. Source: Pfizer Inc. Market Makers. They spread it on the ground, untreated, for it’s fertilizer value. Former U.S. Secretary of Agriculture. Powered by Campfire Digital. Bion’s technology addresses both of these inescapable challenges that will require significant investment over the coming years. Greenhouse gas, ammonia, hydrogen sulfide and odor emissions are dramatically reduced. Ron Kreider Source: Pfizer Inc. In This Story BNTX. That’s the key: how to pay for cleanup. Verified. Bion is a recognized leader in both technology and policy development in this transformation and stands to be a central player as it unfolds. Media Relations Amy Rose +1 (212) 733-7410 Amy.Rose@pfizer.com. Investors. Ultimately, the greatest ‘driver’ for Bion may be America’s and the world’s buying habits, that are undergoing a fundamental shift. 55131 Mainz BioNTech: Media Relations Jasmina Alatovic +49 (0)6131 9084 1513 Media@biontech.de. Investor Relations Chuck Triano +1 (212) 733-3901 Charles.E.Triano@Pfizer.com. The livestock industry has struggled for the last decade to deal with rising fuel costs and drought conditions that have exposed critical weaknesses in its supply chain. Mar 10, … Water is treated sufficiently (including pathogen kill) for re-use by the herd, irrigation or aquifer recharge. BioNTech Contacts: Media Relations Jasmina Alatovic +49 6131 9084-0 Media@biontech.de. Bion’s technology platform enables clean state-of-the-art livestock facilities to be developed in new strategic locations that substantially reduce logistics costs, improve economics and reduce carbon footprint. Excess nutrients – nitrogen and phosphorus – cause toxic algal blooms and dead zones that the EPA now calls the greatest water quality problem in the U.S. today. Investor Relations: Sylke Maas, Ph.D., VP Investor Relations & Business Strategy Tel: +49 (0)6131 9084 1074 E-mail: Investors@biontech.de. Bion’s technology platform creates value from the waste stream in several ways. And while today Pennsylvania is in the spotlight, many other agricultural states now face similar problems and decisions, and more will over the coming years. Perhaps the greatest value Bion’s technology brings, is that the verification of the environmental benefits also forms the basis for a sustainable brand that will communicate the steps taken to reduce environmental impacts to the consumer. There is tremendous waste and inefficiency in this antiquated practice, in addition to completely unsustainable environmental and public health impacts. At Stock Options Channel, our … Real-World Evidence Confirms High Effectiveness of Pfizer-BioNTech COVID-19 Vac.. Pfizer-BioNTech’s COVID-19 Vaccine Arrives in Rwanda. Bion’s direct treatment of livestock waste can provide large-scale verifiable nutrient reductions at significantly lower cost than current agricultural and downstream treatment strategies. Investor Relations Sylke Maas, Ph.D. +49 (0)6131 9084 1074 Investors@biontech.de Pfizer Media Relations Amy Rose +1 (212) 733-7410 Amy.Rose@Pfizer.com. U.S. clean water costs – $114 billion in 2010 – are escalating while overall water quality continues to decline. BioNTech Contacts: Media Relations Jasmina Alatovic +49 (0)6131 9084 1513 or +49 (0)151 1978 1385 Media@biontech.de. Bion is confident that these policy reforms will be achieved in Pennsylvania in the near future, as they face significant sanctions and costs related to the Chesapeake Bay, as well as their own water quality issues. BioNTech Media Relations Jasmina Alatovic +49 (0)6131 9084 1513 or +49 (0)151 1978 1385 Media@biontech.de. Investor Relations Global Contacts Global News Select Pfizer, BioNTech Agree to Supply 4 Million More Vaccine Doses to EU Provided by Dow Jones. Investor Relations Chuck Triano +1 (212) 733-3901 Charles.E.Triano@Pfizer.com. Dan Glickman Current manure handling/spreading expenses can be eliminated. SB575, the bill’s successor was introduced in the Senate in June 2019 and is strongly supported by a PA legislative leadership on both sides of the aisle. BioNTech SE The industry is ready to be engaged and supports these changes. Cleanup is inevitable, but complicated; the industry is not regulated under the Clean Water Act and its margins are thin – the money is just not there. Investor Relations Sylke Maas, Ph.D. +49 (0)6131 9084 1074 Investors@biontech.de Contacts Pfizer: Media Relations Amy Rose +1 (212) 733-7410 Amy.Rose@pfizer.com The Director/Senior Director, Capital Markets & Investor Relations will be responsible for ensuring BioNTech is strategically positioned with external stakeholders in the US. Pilot studies indicate that under certain conditions and locations, more fully described in the current Company Overview and SEC filings, projects can be developed that can be supported by coproduct and renewable energy production alone. Data Provided by Refinitiv. BioNTech is funded by 16 investors. BioNTech Contacts: Media Relations Jasmina Alatovic +49 (0) 6131 9084 1513 Media@biontech.de. Source: Pfizer Inc. All documents on this website speak as of their date and the Company undertakes no obligation to publicly update or revise any forward-looking statements they may contain. CEO and president, Kreider Farms, Auditor An der Goldgrube 12 BioNTech has acquired Neon Therapeutics on Jan 16, 2020. Legislation to apply the federal energy tax credit to nutrient recovery was recently introduced in the U.S. House and Senate and enjoys bipartisan support. BioNTech Media Relations Jasmina Alatovic Senior Manager Global External Communications Tel: +49 (0)6131 9084 7640 or +49 (0)151 1978 1385 E-mail: media@biontech.de BioNTech Investor Relations Sylke Maas, Ph.D. VP Investor Relations & Business Strategy Tel: +49 (0)6131 9084 1074 E-mail: Investors@biontech.de. In other words, the benefits/ value from treatment, more than offset the cost. Minimum 15 minutes delayed. We exploit a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Media Relations Amy Rose +1 (212) 733-1226 PfizerMediaRelations@pfizer.com. The industry knows it needs to clean up. Bion expects a competitive procurement program to be implemented in Pennsylvania in 2018. Pfizer Media Relations Amy Rose (U.S.) Pfizer Media Relations Amy Rose (U.S.) BioNTech Contacts: Media Relations Jasmina Alatovic +49 (0) 6131 9084 1513 Media@biontech.de. 7001 E Belleview Ave, Suite 700 Media Relations Jerica Pitts +1 (212) 733-1226 Jerica.Pitts@pfizer.com Investor Relations Chuck Triano +1 (212) 733-3901 Charles.E.Triano@Pfizer.com BioNTech Contacts: Media Relations Jasmina Alatovic +49 (0)6131 9084 1513 or +49 (0)151 1978 1385 Media@biontech.de Investor Relations Sylke Maas, Ph.D. +49 (0)6131 9084 1074 Investors@biontech.de Further, the industry has now recognized that it will need to verify and communicate this improved sustainability to the consumer. German Federal Ministry of Education and Research (BMBF) and Temasek Holdings are the most recent investors. Bion’s platform also provides dramatic reductions of greenhouse gas, ammonia and hydrogen sulfide emissions, as well as pathogens in the waste stream that have been linked to foodborne illnesses and antibiotic resistance. Bion is a technology and policy leader in this new ‘space’ that is developing at the intersection of the $200B animal-protein industry and the $100B clean water sector. BioNTech is registered under the ticker NASDAQ:BNTX . Because land is no longer required to spread waste on, divesting acreage or expansion on existing acreage can be considered.

Wohnung Scheckenstr Essen, Kommt Ex Freundin Wieder Zurück, Nominalisierung Und Verbalisierung übungen Mit Lösungen Pdf, Frank Rosin Ehefrau, Lobotomy Corporation Story, Dq11 Achat Der Evolution, Vollmacht Schlüsselübergabe Arbeitnehmer,